Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...

The blood-brain barrier in humans is a membrane for preventing solutes from entering the central nervous system. The blood-brain barrier is a network of blood vessels and tissue composed of tightly ...

The drug discovery process is well known to be lengthy and costly, making it imperative that new approaches are explored to increase the efficiency with which novel therapeutic candidates can be ...

By learning the relevant features of clinical images along with the relationships between them, the neural network can outperform more traditional methods.

Gut bacteria are known to be a key factor in many health-related concerns. However, the number and variety of them is vast, as are the ways in which they interact with the body's chemistry and each ...

Rats exhibit significant recovery of locomotor function following incomplete spinal cord injuries, albeit with altered gait expression and reduced speed and stepping frequency. These changes likely ...

GREmLN leverages a graph-based architecture to represent gene-gene interactions to predict cell behavior for therapeutic ...

GREmLN focuses on the “molecular logic” that defines how genes interact and influence each other. This illustration highlights how the model uniquely captures gene interaction and the influence of ...

Machine learning has revolutionized the high-dimensional representations for molecular properties such as potential energy. However, there are scarce machine learning models targeting tensorial ...